Evidence map›Paper›PMID 31950578›Full record

ArticleHuman mutation2020

Single-molecule detection of cancer mutations using a novel PCR-LDR-qPCR assay.

Cristian Ruiz, Jianmin Huang, Sarah F Giardina, Philip B Feinberg, Aashiq H Mirza, Manny D Bacolod, Steven A Soper, Francis Barany

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Human mutation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Cristian RuizDepartment of Microbiology and Immunology, Weill Cornell Medicine, New York, New York.ORCID 0000-0003-0039-5180
Jianmin HuangDepartment of Microbiology and Immunology, Weill Cornell Medicine, New York, New York.
Sarah F GiardinaDepartment of Microbiology and Immunology, Weill Cornell Medicine, New York, New York.ORCID 0000-0002-8879-9384
Philip B FeinbergDepartment of Microbiology and Immunology, Weill Cornell Medicine, New York, New York.
Aashiq H MirzaDepartment of Microbiology and Immunology, Weill Cornell Medicine, New York, New York.
Manny D BacolodDepartment of Microbiology and Immunology, Weill Cornell Medicine, New York, New York.ORCID 0000-0002-2085-4877
Steven A SoperDepartment of Mechanical Engineering, The University of Kansas, Lawrence, Kansas.
Francis BaranyDepartment of Microbiology and Immunology, Weill Cornell Medicine, New York, New York.ORCID 0000-0002-4142-1480
Cornell University · USCalifornia State University, Northridge · USUniversity of Kansas · US

Funding

Using Integrated Omics to Identify Dysfunctional Genetic Mechanisms Influencing Schizophrenia and Sleep DisturbancesP20GM130423 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Kalyani Pyaram, Steven Allan Soper · 2019 to 2026
$21.5M
Single-Molecule Processing: Detection and Identification of Single DNAs, RNAs, and Proteins using Immobilized Nanoscale Enzymatic Reactors (INERs) and Nanoscale ElectrophoresisP41EB020594 · NIBIB · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Sunggook Park · 2015 to 2026
$15.2M
NIBIB NIH HHS P41 EB020594NIGMS NIH HHS P20 GM130423
6 · The paper itself

Abstract

Detection of low-abundance mutations in cell-free DNA is being used to identify early cancer and early cancer recurrence. Here, we report a new PCR-LDR-qPCR assay capable of detecting point mutations at a single-molecule resolution in the presence of an excess of wild-type DNA. Major features of the assay include selective amplification and detection of mutant DNA employing multiple nested primer-binding regions as well as wild-type sequence blocking oligonucleotides, prevention of carryover contamination, spatial sample dilution, and detection of multiple mutations in the same position. Our method was tested to interrogate the following common cancer somatic mutations: BRAF:c.1799T>A (p.Val600Glu), TP53:c.743G>A (p.Arg248Gln), KRAS:c.35G>C (p.Gly12Ala), KRAS:c.35G>T (p.Gly12Val), KRAS:c.35G>A (p.Gly12Asp), KRAS:c.34G>T (p.Gly12Cys), and KRAS:c.34G>A (p.Gly12Ser). The single-well version of the assay detected 2-5 copies of these mutations, when diluted with 10,000 genome equivalents (GE) of wild-type human genomic DNA (hgDNA) from buffy coat. A 12-well (pixel) version of the assay was capable of single-molecule detection of the aforementioned mutations at TP53, BRAF, and KRAS (specifically p.Gly12Val and p.Gly12Cys), mixed with 1,000-2,250 GE of wild-type hgDNA from plasma or buffy coat. The assay described herein is highly sensitive, specific, and robust, and potentially useful in liquid biopsies.

Indexed as

Point MutationReal-Time Polymerase Chain ReactionAllelesAmino Acid SubstitutionBiomarkers, TumorCell Line, TumorCirculating Tumor DNADNA Mutational AnalysisGenotypeHumansNeoplasmsSingle Molecule ImagingBiomarkers, TumorCirculating Tumor DNAcancercirculating tumor DNAearly cancer detectionligase detection reactionmutation

Identifiers

PMID31950578
PMCPMC7160051
OpenAlexW2999738019

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.